600380.SS SHH
Joincare Pharmaceutical Group Industry Co.,Ltd.
1W: +8.3%
1M: +10.3%
3M: +2.9%
YTD: -13.2%
1Y: -17.1%
3Y: -13.9%
5Y: -20.1%
¥10.16 ($1.52)
+0.26 (+2.63%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$3.6B
-7.4% ▼
5Y CAGR: +9.5%
Capital Expenditures
$979M
+13.4% ▲
5Y CAGR: +6.8%
Free Cash Flow
$2.7B
-5.1% ▼
5Y CAGR: +10.6%
Dividends Paid
$468M
-39.0% ▼
Buybacks
$1.2B
-44.6% ▼
Net Change in Cash
-$498M
-142.9% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $2.6B | $2.6B | $2.9B | $1.4B | $3.0B |
| Depreciation & Amort. | $547M | $620M | $838M | $1.1B | $900M |
| Stock-Based Comp. | $36M | $35M | $57M | $0 | $0 |
| Change in Working Capital | -$152M | -$910M | -$76M | -$398M | -$441M |
| Other Non-Cash Items | $99M | $251M | $193M | $1.9B | $194M |
| Operating Cash Flow | $3.0B | $2.6B | $4.0B | $3.9B | $3.6B |
| — Investing Activities — | |||||
| Capital Expenditures | -$830M | -$1.5B | -$1.1B | -$1.1B | -$979M |
| Acquisitions (Net) | $5M | $3M | $49M | -$22M | $0 |
| Investment Purchases | -$157M | -$786M | -$416M | -$205M | -$1.3B |
| Investment Sales | $384M | $270M | $415M | $641M | $1.1B |
| Other Investing | $98M | $70M | -$1.2B | -$305M | -$32M |
| Investing Cash Flow | -$500M | -$2.0B | -$2.3B | -$1.0B | -$1.2B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$186M | $941M | $1.6B | $883M | -$639M |
| Stock Repurchased | -$504M | -$938M | -$781M | -$822M | -$1.2B |
| Dividends Paid | -$308M | -$289M | -$278M | -$337M | -$468M |
| Other Financing | -$240M | -$689M | $4M | -$2.5B | -$740M |
| Financing Cash Flow | -$1.2B | -$975M | $566M | -$1.9B | -$3.0B |
| Net Change in Cash | $1.2B | -$425M | $2.5B | $1.2B | -$498M |
| Cash End of Period | $12.1B | $11.7B | $14.2B | $15.3B | $14.8B |
| Free Cash Flow | $2.2B | $1.0B | $2.8B | $2.8B | $2.7B |